[A combined perfusion-compartmental pharmacokinetic model used to estimate presystemic metabolism of erythromycin in dogs]. 1986

S K Huang, and X Wu, and S Hang, and R Yang, and H T Zhuo

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

S K Huang, and X Wu, and S Hang, and R Yang, and H T Zhuo
March 1987, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
S K Huang, and X Wu, and S Hang, and R Yang, and H T Zhuo
January 1978, Drug metabolism and disposition: the biological fate of chemicals,
S K Huang, and X Wu, and S Hang, and R Yang, and H T Zhuo
February 2000, Toxicology and applied pharmacology,
S K Huang, and X Wu, and S Hang, and R Yang, and H T Zhuo
January 2021, Frontiers in pharmacology,
S K Huang, and X Wu, and S Hang, and R Yang, and H T Zhuo
April 1998, Alimentary pharmacology & therapeutics,
S K Huang, and X Wu, and S Hang, and R Yang, and H T Zhuo
January 2020, Anesthesia and pain medicine,
S K Huang, and X Wu, and S Hang, and R Yang, and H T Zhuo
July 1994, The American journal of physiology,
S K Huang, and X Wu, and S Hang, and R Yang, and H T Zhuo
July 1995, The American journal of physiology,
S K Huang, and X Wu, and S Hang, and R Yang, and H T Zhuo
July 1991, The American journal of physiology,
S K Huang, and X Wu, and S Hang, and R Yang, and H T Zhuo
April 1979, Journal of pharmacokinetics and biopharmaceutics,
Copied contents to your clipboard!